These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 8239542)

  • 1. Effect of DNA topoisomerase I inhibitor, 10-hydroxycamptothecin, on the structure and function of nuclei and nuclear matrix in bladder carcinoma MBT-2 cells.
    Ling YH; Perez-Soler R; Tseng MT
    Anticancer Res; 1993; 13(5A):1613-7. PubMed ID: 8239542
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differentiation induction of human promyelocytic leukemia cells by 10-hydroxycamptothecin, a DNA topoisomerase I inhibitor.
    Ling YH; Tseng MT; Nelson JA
    Differentiation; 1991 Mar; 46(2):135-41. PubMed ID: 1648523
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of phosphorylation of histone H1 and H3 induced by 10-hydroxycamptothecin, DNA topoisomerase I inhibitor, in murine ascites hepatoma cells.
    Ling YH; Xu B
    Zhongguo Yao Li Xue Bao; 1993 Nov; 14(6):546-50. PubMed ID: 8010056
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of hydroxycamptothecin in the activity of RNA and DNA polymerases prepared from murine hepatoma cells.
    Xu B; Ling YH
    Am J Chin Med; 1985; 13(1-4):23-31. PubMed ID: 4025212
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apoptosis induction and cell cycle perturbation in human hepatoma hep G2 cells by 10-hydroxycamptothecin.
    Zhang XW; Qing C; Xu B
    Anticancer Drugs; 1999 Jul; 10(6):569-76. PubMed ID: 10885905
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of antileukemia agents on nuclear matrix-bound DNA replication in CCRF-CEM leukemia cells.
    Fernandes DJ; Smith-Nanni C; Paff MT; Neff TA
    Cancer Res; 1988 Apr; 48(7):1850-5. PubMed ID: 3349463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA topoisomerase I as a site of action for 10-hydroxycamptothecin in human promyelocytic leukemia cells.
    Ling YH; Andersson BS; Nelson JA
    Cancer Biochem Biophys; 1990 Jan; 11(1):23-30. PubMed ID: 2159843
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anticancer properties of 10-hydroxycamptothecin in a murine melanoma pulmonary metastasis model in vitro and in vivo.
    Hu W; Zhang C; Fang Y; Lou C
    Toxicol In Vitro; 2011 Mar; 25(2):513-20. PubMed ID: 21093576
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The effect of hydroxycamptothecin and topotecan to SKOV3 and CAOV3 in vitro].
    Sun Z; Shen K; Xu X
    Zhonghua Fu Chan Ke Za Zhi; 1999 Sep; 34(9):547-50. PubMed ID: 11360641
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Lethal effect of adenovirus-mediated HSV-TK gene in combination with hydroxycamptothecin on human bladder cancer in vitro].
    Huang H; Tan WL; Zhu WH; Liang ZK
    Nan Fang Yi Ke Da Xue Xue Bao; 2007 Apr; 27(4):461-4. PubMed ID: 17545031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of endonucleolytic DNA cleavage in human acute myelogenous leukemia cells by etoposide, camptothecin, and other cytotoxic anticancer drugs: a cautionary note.
    Kaufmann SH
    Cancer Res; 1989 Nov; 49(21):5870-8. PubMed ID: 2790800
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antisense protein kinase A RIalpha acts synergistically with hydroxycamptothecin to inhibit growth and induce apoptosis in human cancer cells: molecular basis for combinatorial therapy.
    Cho YS; Cho-Chung YS
    Clin Cancer Res; 2003 Mar; 9(3):1171-8. PubMed ID: 12631623
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced nuclear delivery and cytotoxic activity of hydroxycamptothecin using o/w emulsions.
    Zhao Y; Gao J; Sun X; Chen H; Wu L; Liang W
    J Pharm Pharm Sci; 2007; 10(1):61-70. PubMed ID: 17498395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intracellular roles of SN-38, a metabolite of the camptothecin derivative CPT-11, in the antitumor effect of CPT-11.
    Kawato Y; Aonuma M; Hirota Y; Kuga H; Sato K
    Cancer Res; 1991 Aug; 51(16):4187-91. PubMed ID: 1651156
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between lactone ring forms of HCPT and their antitumor activities.
    Zhou JJ; Liu J; Xu B
    Acta Pharmacol Sin; 2001 Sep; 22(9):827-30. PubMed ID: 11749865
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined effects of hyperthermia and CPT-11 on DNA strand breaks in mouse mammary carcinoma FM3A cells.
    Kondo T; Ueda K; Kano E
    Anticancer Res; 1995; 15(1):83-6. PubMed ID: 7733646
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Topoisomerase II cleavable complex formation within DNA loop domains.
    Lambert JM; Fernandes DJ
    Biochem Pharmacol; 2000 Jul; 60(1):101-9. PubMed ID: 10807951
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Behavior of nuclear matrix proteins during camptothecin-induced apoptosis in HL-60 human leukemia cells.
    Zweyer M; Bareggi R; Grill V; Soranzo MR; Marugg RA; Riederer BM; Narducci P; Martelli AM
    Exp Cell Res; 1995 Nov; 221(1):27-40. PubMed ID: 7589253
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sensitivity to camptothecin of human breast carcinoma and normal endothelial cells.
    Jones CB; Clements MK; Wasi S; Daoud SS
    Cancer Chemother Pharmacol; 1997; 40(6):475-83. PubMed ID: 9332461
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [In vitro study of radiation sensitizing effect of hydroxycamptothecin].
    Wang L; Yang W
    Zhonghua Zhong Liu Za Zhi; 2000 Mar; 22(2):124-6. PubMed ID: 11776638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.